Supplemental Figure 1: Pituitary response at different stimulation tests and growth charts of the patient with IGSF1 deletion. A)
At initial diagnosis of the patient, and to rule out a possible combined pituitary hormone deficiency (CPHD), serum basal growth hormone (GH) was determined in two occasions showing normal values. B) a Synacthen ® (ACTH) stimulation test was performed as neonate (15 days of life) with normal results (peak >20 µg/dl), discarding cortisol deficiency. C) TRH stimulation tests at 3, 6 and 14 years of age showed a mild improvement in the TSH peak response to TRH along with age. A similar improvement has been described in one patient with congenital central hypothyroidism (15) and could be related to the repeated exposure of the pituitary to TRH at previous tests (Beck-Peccoz P, Amr S, Menezes-Ferreira MM, Faglia G, Weintraub BD. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism.
Effect of treatment with thyrotropin-releasing hormone. N Engl J Med. 1985; 312(17):1085-90) . D) Repeated (two) TRH stimulation tests in the mother of the patient at 36 years of age, showed a flat TSH response to TRH, consistent with a pituitary defect not related to L-T4 treatment. E-F) Height and weight charts of the patient showing normal growth within the 50th percentile in both curves, further ruling out GH deficiency. A physiological and transient deceleration of height and weight is observed during peri-pubertal stages. Adult height at 20 years of age reached 175 cm, which is actually higher than his calculated target-height of 169 cm. deletion developed a progressive macroorchidism observed since 3 years of age, with a testicular size of 3 ml (>p98), which continued increasing above percentile 98 until 12 years of age. At the age of 14 the testicular volume markedly increased, along with the expected and normal elevation of FSH levels during puberty. Reference chart for testicular volume from Joustra SD, van der Plas EM, Goede J, Oostdijk W, Delemarre-van de Waal HA, Hack WW, van Buuren S, Wit JM. New reference charts for testicular volume in Dutch children and adolescents allow the calculation of standard deviation scores. Acta Paediatr. 2015 104(6):e271-278. Transfection of IGSF1 duplicate the activity of the human TRHR promoter. Addition of Activin does not affect the basal activity nor the IGSF1 induction, and consequently the receptor inhibitor SB431542 has no effect. The promoter is affected neither by a SMAD2 dominant negative (DSMAD2) nor by an Activin receptor constitutively activated mutant (caALK4).
